Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Erik F. Eriksen"'
Autor:
Erik F. Eriksen, Rogely W. Boyce, Yifei Shi, Jacques P. Brown, Stéphane Horlait, Cesar Libanati, Roland Chapurlat, Pascale Chavassieux
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 100781- (2021)
Externí odkaz:
https://doaj.org/article/defb70bd6c1641088d02119216a220d3
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 100835- (2021)
Externí odkaz:
https://doaj.org/article/76840a351e2b40fbbc8bc475610f2408
Autor:
Erik F. Eriksen, Roland Chapurlat, Rogely Boyce, Jacques P. Brown, Stéphane Horlait, Cesar Libanati, Yifei Shi, Rachel B. Wagman, Pascale Chavassieux
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100440- (2020)
Externí odkaz:
https://doaj.org/article/0147a0671a024bb7a0e232e742d863c6
Autor:
RENE RIZZOLI, NANSA BURLET, DAVID CAHALL, PIERRE D. DELMAS, ERIK F. ERIKSEN, DIETER FELSENBERG, JOHN GRBIC, MATS JONTELL, REGINA LANDESBERG, ANDREA LASLOP, PETER MATTON, SOCRATES PAPAPOULOS, ORHAN SEZER, MICHAEL SPRAFKA, JEAN-YVES REGINSTER
Publikováno v:
Остеопороз и остеопатии, Vol 10, Iss 2, Pp 19-21 (2007)
Externí odkaz:
https://doaj.org/article/d819336675f54f91859955db5079b64e
Autor:
Pamela Rufus-Membere, Kara L. Holloway-Kew, Adolfo Diez-Perez, Natasha M. Appelman-Dijkstra, Mary L. Bouxsein, Erik F. Eriksen, Joshua N. Farr, Sundeep Khosla, Mark A. Kotowicz, Xavier Nogues, Mishaela Rubin, Julie A. Pasco
Publikováno v:
Calcified Tissue International and Musculoskeletal Research, 112, 338-349. SPRINGER
Impact microindentation (IMI) is a novel technique for assessing bone material strength index (BMSi) in vivo, by measuring the depth of a micron-sized, spherical tip into cortical bone that is then indexed to the depth of the tip into a reference mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c54a49891e56e2391cd34ebf719ad84
https://hdl.handle.net/1887/3619433
https://hdl.handle.net/1887/3619433
Autor:
Eleftherios P. Paschalis, Sonja Gamsjaeger, Klaus Klaushofer, Elizabeth Shane, Adi Cohen, Jan Stepan, Imre Pavo, Erik F. Eriksen, Kathleen A. Taylor, David W. Dempster
Publikováno v:
Bone. 162
Postmenopausal osteoporosis (PMOP) therapies are frequently evaluated by bone mineral density (BMD) gains against patients receiving placebo (calcium and vitamin D supplementation, a mild bone turnover-suppressing intervention), which is not equivale
Autor:
null Tove T Borgen, null Lene B Solberg, null Trine Lauritzen, null Ellen M. Apalset, null Åshild Bjørnerem, null Erik F Eriksen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6abff8974f9de5c5991ba3d0f20fddcd
https://doi.org/10.1002/jbm4.10633/v2/response1
https://doi.org/10.1002/jbm4.10633/v2/response1
Autor:
Tove T Borgen, Lene B Solberg, Trine Lauritzen, Ellen M Apalset, Åshild Bjørnerem, Erik F Eriksen
Publikováno v:
e10633
JBMR Plus
JBMR Plus
The serum bone turnover markers (BTM) procollagen type 1 N-terminal propeptide (P1NP) and C-terminal cross-linking telopeptide of type 1 collagen (CTX) are recommended for monitoring adherence and response of antiresorptive drugs (ARD). BTM are eleva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3144eb12745a852381af74302563d64b
https://hdl.handle.net/11250/3034801
https://hdl.handle.net/11250/3034801
Autor:
Ian R. Reid, Jonathan R. Green, Kenneth W. Lyles, David M. Reid, Ulrich Trechsel, David J. Hosking, Dennis M. Black, Steven R. Cummings, R. Graham G. Russell, Erik F. Eriksen
Publikováno v:
Bone. 137
Zoledronate is the most potent and most long-acting bisphosphonate in clinical use, and is administered as an intravenous infusion. Its major uses are in osteoporosis, Paget's disease, and in myeloma and cancers to reduce adverse skeletal related eve
Autor:
Eleftherios P, Paschalis, John H, Krege, Sonja, Gamsjaeger, Erik F, Eriksen, David B, Burr, Damon P, Disch, Jan J, Stepan, Astrid, Fahrleitner-Pammer, Klaus, Klaushofer, Fernando, Marin, Imre, Pavo
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 33(12)
Teriparatide increases bone mass primarily through remodeling of older or damaged bone and abundant replacement with new mineralizing bone. This post hoc analysis investigated whether dual-energy X-ray absorptiometric (DXA) areal bone mineral density